HIV Single Therapy PRO 140 Will Enable CytoDyn Inc. (CYDY) to “Take Off” Very Soon, President and CEO Says

October 30, 2018 10:00:40
  • Positive results in the PRO 140 clinical trials should mean good news for investors, CytoDyn President Nader Pourhassan said in an interview
  • CytoDyn is currently undervalued but the effectiveness and practical appeal of PRO 140 should contribute to a turning point in stock prices
  • PRO 140, a single agent therapy, is proving highly effective in the treatment of HIV; CytoDyn also planning an expansion of clinical trials to certain types of cancer

The growth potential of CytoDyn Inc. (OTCQB: CYDY) is huge, company President and CEO Dr. Nader Pourhassan said in an interview with The Wall Street Transcript ( According to Pourhassan, CytoDyn is undervalued for the time being, but PRO 140 is expected to contribute significantly to the growth of company stock value.

Pourhassan was appointed director in 2012, and, ever since, he has been responsible for driving the opportunity of PRO 140 as a single agent therapy for HIV, from Phase II development and into Phase III trials, including the development of…

Read More>>

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.